NOVARTIS logo.jpg
New Novartis analyses for investigational inclisiran demonstrate consistently effective and sustained LDL-C reduction at month 17 regardless of age and gender
November 13, 2020 10:00 ET | Novartis International AG
 Pooled data analyses from Phase III ORION-9, -10 and -11 showed that inclisiran consistently reduced low-density lipoprotein cholesterol (LDL-C) by approximately 51% in both male and female adult...
InCarda Logo.png
InCarda Therapeutics Presents Positive New Data from Phase 2 Study of InRhythm™ in Patients with Paroxysmal Atrial Fibrillation at American Heart Association Scientific Sessions 2020
November 13, 2020 10:00 ET | InCarda Therapeutics, Inc.
Data Demonstrate Achievement of Rapid Conversions from Atrial Fibrillation to Normal Sinus Rhythm Study Findings Provide Proof of Concept for First-of-its-Kind Inhaled Antiarrhythmic for Treatment of...
Amarin_Logo_JPEG.jpg
VASCEPA® (Icosapent Ethyl) Found to Significantly Reduce Ischemic Events in Patients with Prior Coronary Artery Bypass Grafting (CABG) Procedures in Post Hoc Subgroup Analyses of Landmark REDUCE-IT® Study Presented at American Heart Association’s Virtual Scientific Sessions 2020
November 13, 2020 10:00 ET | Amarin Corporation plc
VASCEPA®, compared with placebo, significantly reduced primary composite first and total major adverse cardiovascular events (MACE) in post hoc exploratory analyses of patients with a history of CABG...
MyoKardia_Logo_RGB.png
MyoKardia Presents Mavacamten Clinical and Non-Clinical Data at the American Heart Association’s Scientific Sessions 2020
November 13, 2020 10:00 ET | MyoKardia, Inc.
ECHO Data from EXPLORER-HCM Show Mavacamten Treatment Improved Cardiac Structure and Mitral Valve Function in Obstructive Hypertrophic Cardiomyopathy Patients Markers of Physical Activity from...
inari logo 2.png
Inari Medical Announces Presentation of Positive 30-Day Follow-Up Results from First Patients in Real World FLASH Registry
November 13, 2020 10:00 ET | Inari Medical, Inc.
IRVINE, Calif., Nov. 13, 2020 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a commercial-stage medical device company focused on developing products to treat and transform the...
ReportLinker logo.jpg
The APAC hyperscale data center market by revenue is expected to grow at a CAGR of close to 4% during the period 2020–2025
November 13, 2020 09:58 ET | ReportLinker
New York, Nov. 13, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Hyperscale Data Center Market in APAC- Industry Outlook and Forecast 2020-2025" -...
Zahng-Investor-Law.png
BMRN UPCOMING DEADLINE: Zhang Investor Law Alerts Investors to Imminent Deadline in Securities Class Action Lawsuit Against  BioMarin Pharmaceutical Inc. – BMRN
November 13, 2020 09:57 ET | Zhang Investor Law P.C.
NEW YORK, Nov. 13, 2020 (GLOBE NEWSWIRE) -- Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) from...
Delårsrapport for 1.
Delårsrapport for 1.-3. kvartal 2020
November 13, 2020 09:54 ET | Brødrene A. & O. Johansen A/S
Meddelelse nr. 10 – 2020   til Nasdaq Copenhagen    2020.11.13 Delårsrapport for 1.-3. kvartal 2020 Omsætningen udgør for 3. kvartal 2020 i alt 979,7 mio. kr., hvilket er 102,3 mio. kr. eller knap...
logo.jpg
Correction: ENGINEERING - BNP Paribas Primary New Issues: Stab trade from 06/10 was missing
November 13, 2020 09:53 ET | BNP Paribas Primary New Issues
13/11/2020 Not for distribution, directly or indirectly, in or into the United States or any jurisdiction in which such distribution would be unlawful. CENTURION BIDCO S.P.A. ...
ReportLinker logo.jpg
The Europe lawn mower market by revenue is expected to grow at a CAGR of over 5% during the period 2020–2025
November 13, 2020 09:53 ET | ReportLinker
New York, Nov. 13, 2020 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Europe Lawn Mower Market - Comprehensive Study and Strategic Analysis 2020?2025" -...